Literature DB >> 26527730

Automated design of hammerhead ribozymes and validation by targeting the PABPN1 gene transcript.

Nawwaf Kharma1, Luc Varin2, Aida Abu-Baker3, Jonathan Ouellet4, Sabrine Najeh4, Mohammad-Reza Ehdaeivand2, Gabriel Belmonte5, Anas Ambri5, Guy Rouleau3, Jonathan Perreault6.   

Abstract

We present a new publicly accessible web-service, RiboSoft, which implements a comprehensive hammerhead ribozyme design procedure. It accepts as input a target sequence (and some design parameters) then generates a set of ranked hammerhead ribozymes, which target the input sequence. This paper describes the implemented procedure, which takes into consideration multiple objectives leading to a multi-objective ranking of the computer-generated ribozymes. Many ribozymes were assayed and validated, including four ribozymes targeting the transcript of a disease-causing gene (a mutant version of PABPN1). These four ribozymes were successfully tested in vitro and in vivo, for their ability to cleave the targeted transcript. The wet-lab positive results of the test are presented here demonstrating the real-world potential of both hammerhead ribozymes and RiboSoft. RiboSoft is freely available at the website http://ribosoft.fungalgenomics.ca/ribosoft/.
© The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26527730      PMCID: PMC4770207          DOI: 10.1093/nar/gkv1111

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  35 in total

Review 1.  Ribozyme gene therapy: applications for molecular medicine.

Authors:  A S Lewin; W W Hauswirth
Journal:  Trends Mol Med       Date:  2001-05       Impact factor: 11.951

2.  The virtues of self-binding: high sequence specificity for RNA cleavage by self-processed hammerhead ribozymes.

Authors:  T Ohmichi; E T Kool
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

Review 3.  Engineered allosteric ribozymes as biosensor components.

Authors:  Ronald R Breaker
Journal:  Curr Opin Biotechnol       Date:  2002-02       Impact factor: 9.740

Review 4.  Approaches for the sequence-specific knockdown of mRNA.

Authors:  Lisa J Scherer; John J Rossi
Journal:  Nat Biotechnol       Date:  2003-12       Impact factor: 54.908

5.  Monitoring post-translational modification of proteins with allosteric ribozymes.

Authors:  Narendra K Vaish; Fang Dong; Lori Andrews; Rebecca E Schweppe; Natalie G Ahn; Lawrence Blatt; Scott D Seiwert
Journal:  Nat Biotechnol       Date:  2002-07-15       Impact factor: 54.908

6.  Sequence elements outside the hammerhead ribozyme catalytic core enable intracellular activity.

Authors:  Anastasia Khvorova; Aurélie Lescoute; Eric Westhof; Sumedha D Jayasena
Journal:  Nat Struct Biol       Date:  2003-07-27

7.  Peripheral regions of natural hammerhead ribozymes greatly increase their self-cleavage activity.

Authors:  Marcos De la Peña; Selma Gago; Ricardo Flores
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

Review 8.  The thermodynamics of DNA structural motifs.

Authors:  John SantaLucia; Donald Hicks
Journal:  Annu Rev Biophys Biomol Struct       Date:  2004

9.  Sfold web server for statistical folding and rational design of nucleic acids.

Authors:  Ye Ding; Chi Yu Chan; Charles E Lawrence
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

10.  Efficient inhibition of beta-secretase gene expression in HEK293 cells by tRNAVal-driven and CTE-helicase associated hammerhead ribozymes.

Authors:  Barbara Nawrot; Slawomir Antoszczyk; Maria Maszewska; Tomoko Kuwabara; Masaki Warashina; Kazunari Taira; Wojciech J Stec
Journal:  Eur J Biochem       Date:  2003-10
View more
  5 in total

1.  Argonaute-based programmable RNase as a tool for cleavage of highly-structured RNA.

Authors:  Daniel M Dayeh; William A Cantara; Jonathan P Kitzrow; Karin Musier-Forsyth; Kotaro Nakanishi
Journal:  Nucleic Acids Res       Date:  2018-09-19       Impact factor: 16.971

2.  PABPN1 gene therapy for oculopharyngeal muscular dystrophy.

Authors:  A Malerba; P Klein; H Bachtarzi; S A Jarmin; G Cordova; A Ferry; V Strings; M Polay Espinoza; K Mamchaoui; S C Blumen; J Lacau St Guily; V Mouly; M Graham; G Butler-Browne; D A Suhy; C Trollet; G Dickson
Journal:  Nat Commun       Date:  2017-03-31       Impact factor: 14.919

Review 3.  Oligonucleotide-Based Approaches to Inhibit Dengue Virus Replication.

Authors:  Kingshuk Panda; Kalichamy Alagarasu; Deepti Parashar
Journal:  Molecules       Date:  2021-02-11       Impact factor: 4.411

4.  MoiRNAiFold: a novel tool for complex in silico RNA design.

Authors:  Gerard Minuesa; Cristina Alsina; Juan Antonio Garcia-Martin; Juan Carlos Oliveros; Ivan Dotu
Journal:  Nucleic Acids Res       Date:  2021-05-21       Impact factor: 16.971

5.  RNA-Based Therapy Utilizing Oculopharyngeal Muscular Dystrophy Transcript Knockdown and Replacement.

Authors:  Aida Abu-Baker; Nawwaf Kharma; Jonathan Perreault; Alanna Grant; Masoud Shekarabi; Claudia Maios; Michele Dona; Christian Neri; Patrick A Dion; Alex Parker; Luc Varin; Guy A Rouleau
Journal:  Mol Ther Nucleic Acids       Date:  2019-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.